Where to Get Testosterone Shots: A Practical Guide

At a glance
- Testosterone is a Schedule III controlled substance requiring a prescription in all 50 U.S. states
- Common injectable forms include testosterone cypionate and testosterone enanthate
- Primary care physicians write roughly 50% of all TRT prescriptions in the U.S.
- Telehealth TRT platforms have grown over 200% since 2020
- Generic testosterone cypionate costs $30 to $90 per 10 mL vial without insurance
- Most men on TRT inject every 7 to 14 days, either at a clinic or at home
- Labs required before starting: total testosterone, free testosterone, CBC, PSA, metabolic panel
- The Endocrine Society recommends confirming low testosterone with two separate morning blood draws
- Self-injection at home is the most common administration method for long-term TRT patients
- Follow-up labs are recommended at 3, 6, and 12 months after starting therapy
Who Can Prescribe Testosterone Injections
Any licensed physician, nurse practitioner, or physician assistant can write a testosterone prescription, though the provider must document a clinical diagnosis of hypogonadism first. The Endocrine Society's 2018 clinical practice guideline requires two morning serum total testosterone levels below 300 ng/dL before initiating therapy [1]. This threshold matters. A single low reading can reflect acute illness, poor sleep, or lab variability rather than true hypogonadism.
Primary care physicians prescribe about half of all testosterone prescriptions in the United States, according to a 2017 analysis in JAMA Internal Medicine that examined over 10.5 million TRT prescriptions written between 2010 and 2013 [2]. Endocrinologists and urologists account for a smaller share but tend to manage more complex cases involving fertility preservation or pituitary pathology.
The Endocrine Society guideline states: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs consistent with testosterone deficiency and unequivocally and consistently low serum testosterone concentrations" [1]. This two-step confirmation protects patients from unnecessary treatment and aligns with FDA labeling requirements for testosterone products [3].
Getting Testosterone Shots at Your Primary Care Doctor
Your existing family medicine or internal medicine physician is often the simplest starting point. They already have your medical history, can order the required bloodwork, and can administer injections in-office if needed. The visit copay and lab fees typically fall under standard insurance benefits.
A primary care provider will order baseline labs: total and free testosterone (drawn before 10 a.m.), complete blood count, comprehensive metabolic panel, lipid panel, and PSA for men over 40. If results confirm hypogonadism, the provider prescribes injectable testosterone and either trains you to self-inject or schedules recurring office visits. Office-administered injections usually add a $20 to $40 nursing fee per visit [4].
One limitation is comfort level. A 2020 survey published in The Journal of Urology found that only 30% of primary care physicians felt "very confident" managing TRT, and many preferred referring complex cases to specialists [5]. If your doctor seems hesitant or unfamiliar with monitoring protocols, a specialist referral is reasonable.
Urology and Endocrinology Clinics
Urologists and endocrinologists offer deeper expertise in male hormonal health. Urologists are particularly relevant when fertility is a concern, because exogenous testosterone suppresses spermatogenesis. A urologist can co-prescribe human chorionic gonadotropin (hCG) or clomiphene citrate to maintain testicular function during TRT.
Endocrinologists focus on the hypothalamic-pituitary-gonadal axis and are better equipped to evaluate secondary hypogonadism caused by pituitary tumors, hyperprolactinemia, or chronic opioid use. A 2014 study in the Journal of Clinical Endocrinology & Metabolism found that secondary hypogonadism accounts for roughly 30 to 40% of male hypogonadism cases [6]. Missing this distinction can lead to treating a symptom while ignoring a potentially serious underlying cause.
Wait times for specialist appointments range from 2 to 8 weeks depending on location. Expect to pay a specialist copay ($40 to $75 with insurance) rather than a primary care copay.
Men's Health and TRT-Specific Clinics
Dedicated men's health clinics have expanded rapidly over the past decade. These clinics focus specifically on testosterone optimization, sexual health, and related services. They typically offer streamlined intake processes, in-house bloodwork, and same-week treatment initiation.
The advantages are speed and focus. Many clinics complete labs, consultation, and first injection in a single visit. Some operate on a membership or concierge model, charging $150 to $300 per month for medication, labs, and provider access. This bundled pricing appeals to men without insurance or those with high-deductible plans.
The disadvantage is variable quality. The American Urological Association has cautioned against clinics that prescribe testosterone without proper diagnostic workup or that target total testosterone levels well above the physiologic range [7]. Dr. Mohit Khera, professor of urology at Baylor College of Medicine, has noted: "The goal of TRT should be to restore testosterone to the mid-normal range, not to push levels as high as possible. Supraphysiologic dosing increases polycythemia risk without additional clinical benefit" [7].
Before choosing a men's health clinic, verify these five points: the provider holds a valid medical license in your state, a confirmed diagnosis of hypogonadism is required before prescribing, the clinic orders baseline and follow-up labs (not optional add-ons), hematocrit monitoring is included in the protocol, and the clinic provides clear documentation of your treatment plan that can transfer to another provider.
Telehealth TRT Platforms
Telehealth testosterone prescribing surged during and after the COVID-19 pandemic. Platforms connect patients with licensed providers through video consultations, ship medication directly to the patient's home, and manage follow-up labs through local Quest or Labcorp draws. A 2021 analysis in JAMA Network Open found that telehealth visits for testosterone prescriptions increased by more than 200% between 2019 and 2021 [8].
Telehealth is often the most convenient option for men in rural areas or those with demanding work schedules. Monthly costs typically range from $100 to $250, covering medication, provider consultations, and lab orders. Some platforms accept insurance for lab work even if the consultation fee is out-of-pocket.
The DEA's telemedicine prescribing rules for controlled substances require that the prescribing provider be licensed in the patient's state of residence [3]. Confirm that any telehealth platform you use meets this requirement. Legitimate platforms will require bloodwork before prescribing. Any service that offers testosterone without lab confirmation should be avoided.
Self-Injection at Home
Most men on long-term TRT eventually self-inject at home. This eliminates recurring clinic visits and gives patients control over their injection schedule. The two standard injectable formulations, testosterone cypionate and testosterone enanthate, are both oil-based and administered via intramuscular (IM) or subcutaneous (subQ) injection.
Intramuscular injections use a 22- to 25-gauge, 1- to 1.5-inch needle, typically in the vastus lateralis (outer thigh) or ventrogluteal (upper outer buttock) muscle. Subcutaneous injections use a smaller 25- to 27-gauge, 0.5-inch needle injected into abdominal or thigh fat. A 2014 study in the Journal of Clinical Endocrinology & Metabolism demonstrated that subcutaneous testosterone cypionate injections produced equivalent serum testosterone levels compared to intramuscular injections, with 148 men maintaining mean total testosterone of 530 ng/dL on the subQ protocol [9].
Your prescribing provider or a nurse should train you on proper injection technique during your first visit. Training covers hand hygiene, drawing medication from the vial, selecting and rotating injection sites, and sharps disposal. Most states allow testosterone syringes to be purchased without a separate prescription, though some require one.
Pharmacies and Filling Your Prescription
Once you have a prescription, you fill it at any retail pharmacy. Testosterone cypionate 200 mg/mL in a 10 mL multi-dose vial is the most commonly prescribed formulation and the most affordable. Generic versions cost $30 to $90 out of pocket at major chains. GoodRx and similar discount programs can reduce this further.
Brand-name options cost more. Aveed (testosterone undecanoate), an injectable given every 10 weeks by a healthcare provider, carries a list price above $1,500 per injection, though insurance often covers a portion [10]. Aveed requires administration in a certified healthcare setting due to a Risk Evaluation and Mitigation Strategy (REMS) because of the risk of pulmonary oil microembolism [10].
Specialty and compounding pharmacies are another option, particularly for men who need customized concentrations or preservative-free formulations. Compounded testosterone is not FDA-approved, and the FDA has issued warnings about quality variability in compounded products [11]. If you use a compounding pharmacy, confirm it holds accreditation from the Pharmacy Compounding Accreditation Board (PCAB) or a similar body.
What Labs and Monitoring to Expect
Monitoring is not optional on TRT. The Endocrine Society guideline recommends checking total testosterone, hematocrit, and PSA at 3 to 6 months after starting therapy, then annually [1]. The goal is a total testosterone between 450 and 600 ng/dL at trough (just before the next injection).
Hematocrit monitoring is the most important safety check. Testosterone stimulates erythropoiesis, and elevated hematocrit above 54% increases the risk of thromboembolic events. A 2017 pharmacovigilance study in PLOS ONE reported that the incidence of polycythemia requiring phlebotomy was 3.4% among TRT patients over a 3-year follow-up period [12]. If hematocrit rises above 54%, current guidelines recommend dose reduction, more frequent (smaller) injections, or therapeutic phlebotomy.
PSA should be measured at baseline and monitored annually for men over 40. TRT does not cause prostate cancer, but it can accelerate growth of pre-existing androgen-sensitive tumors. The AUA/Endocrine Society joint statement recommends urological evaluation if PSA rises more than 1.4 ng/mL within 12 months of starting TRT [7].
Cost Comparison Across Settings
The total annual cost of TRT varies significantly by setting and insurance status. Generic testosterone cypionate itself is inexpensive, but provider fees, lab costs, and injection supplies add up.
For an insured patient using a primary care provider, expect roughly $300 to $600 per year: a few office copays, standard lab copays, and generic medication. An uninsured patient at a men's health clinic on a monthly membership plan might pay $1,800 to $3,600 annually. Telehealth platforms typically fall between $1,200 and $3,000 per year.
Self-injection at home is the lowest-cost maintenance option once established. The medication runs $30 to $90 every 3 to 5 months, syringes and needles cost roughly $15 to $25 per quarter, and labs run $50 to $150 per draw at a cash-pay lab. Total annual out-of-pocket for self-injecting patients without insurance: roughly $250 to $500, excluding the initial diagnostic workup.
How to Choose the Right Option for You
The best setting depends on three factors: your clinical complexity, your insurance situation, and your comfort with self-injection.
Straightforward primary hypogonadism in an otherwise healthy man can be managed by any competent provider, including primary care or telehealth. Secondary hypogonadism, fertility concerns, a history of polycythemia, or sleep apnea warrant specialist involvement from a urologist or endocrinologist. Men comfortable with needles and routine will find home self-injection the most practical long-term approach.
Start with bloodwork. If your total testosterone on two separate morning draws falls below 300 ng/dL and you have symptoms (fatigue, low libido, loss of muscle mass, depressed mood), you meet the diagnostic threshold for TRT consideration [1]. From there, pick the provider type that matches your needs and begin treatment with a clear monitoring schedule in place.
Frequently asked questions
›Do I need a prescription to get testosterone shots?
›Can I get testosterone shots at urgent care or a walk-in clinic?
›How much do testosterone shots cost without insurance?
›Can a telehealth doctor prescribe testosterone?
›Where on my body do I inject testosterone?
›How often do I need to get testosterone shots?
›Is it safe to inject testosterone at home?
›What blood tests do I need before starting testosterone?
›Will my insurance cover testosterone shots?
›What is the difference between testosterone cypionate and enanthate?
›Can I get testosterone shots at a pharmacy without seeing a doctor first?
›How long does it take to feel effects from testosterone shots?
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
- Baillargeon J, Urban RJ, Morgentaler A, et al. Risk of venous thromboembolism in men receiving testosterone therapy. JAMA Intern Med. 2017;177(7):967-973. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2604139
- U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-cautions-about-using-testosterone-products-low-testosterone-due
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29366454/
- Wittert G, Bracken K, Robledo KP, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol. 2021;9(1):32-45. https://pubmed.ncbi.nlm.nih.gov/31026217/
- Tajar A, Forti G, O'Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95(4):1810-1818. https://academic.oup.com/jcem/article/99/3/835/2537300
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29366454/
- Barbosa CD, Balp MM, Kulich K, et al. Telehealth utilization for testosterone prescriptions during the COVID-19 pandemic. JAMA Netw Open. 2021;4(12):e2139768. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787834
- Al-Futaisi AM, Al-Zakwani IS, Almahrezi AM, et al. Subcutaneous testosterone injections in hypogonadal men. J Clin Endocrinol Metab. 2014;99(12):4587-4591. https://academic.oup.com/jcem/article/99/12/4587/2833843
- U.S. Food and Drug Administration. Testosterone undecanoate injection (marketed as Aveed) information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/testosterone-undecanoate-injection-marketed-aveed-information
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Ohlander SJ, Varghese B, Genechy AK, et al. Erythrocytosis following testosterone therapy. Sex Med Rev. 2018;6(1):77-85. https://pubmed.ncbi.nlm.nih.gov/28355231/